APO vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

APO

69.0
AI Score
VS
APO Wins

FHI

59.6
AI Score

Investment Advisor Scores

APO

69score
Recommendation
BUY

FHI

60score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric APO FHI Winner
Revenue 16.21B 981.73M APO
Net Income -545.00M 200.70M FHI
Net Margin -3.4% 20.4% FHI
ROE -2.6% 16.0% FHI
ROA -0.1% 8.6% FHI
Total Assets 494.05B 2.33B APO
Debt/Equity 0.65 0.28 FHI

Relative Price Performance (Last 90 Days)

APO 1M: -7.7% · 3M: -6.3% FHI 1M: +0.2% · 3M: -0.4%

Current Technical Phase

APO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.2%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $114.83

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.6 · Price: $57.67

Fundamentals Snapshot

Metric APO FHI
Market Cap — —
Forward P/E 10.8 9.7
Trailing P/E 40.0 10.4
Revenue (TTM) — —
Revenue Growth 0.6% 0.2%
Gross Margin 0.4% 0.7%
Operating Margin 0.2% 0.3%
EPS 2.79 5.37
Dividend Yield 0.02% 0.03%

Frequently Asked Questions

Based on our detailed analysis, APO is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.